Overview

Pilot Study of Metformin in HNSCC to Investigate the Effects of MF, Tumor Genotype and MF-genotype Interactions, on Tumor Metabolism and Anoikis

Status:
Terminated

Trial end date:
2016-08-01

Target enrollment:

Participant gender:

Summary

The study researchers want to look at the overall effects that Metformin may have on the tumor characteristics of Head and Neck cancer cells as well as the interactions that Metformin has on the growth or death of tumor cells.

Phase:

Early Phase 1

Details

Lead Sponsor:

West Virginia University

Collaborators:

West Virginia Clinical & Translational Science Institute
West Virginia Clinical and Translational Science Institute

Treatments:

Metformin